drug prices

Market Access

The UK-US drug pricing deal: A welcome step, but not the fin...

The UK-US deal eases medicines pricing uncertainty, lifts NICE threshold, and boosts confidence, but UK pharma still needs pricing reform

News

Ozempic tops new Medicare price negotiation list

On their way out the door, the Biden administration has dropped the list of the next 15 drugs to be negotiated by Medicare.

Market Access

Looking to history to prepare for America’s uncertain future

In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration

Sales & Marketing

How buying Canadian insulin aids Americans without medical c...

The rising cost of medication in the United States has become a critical issue, significantly impacting the lives of millions across the nation.

Views & Analysis

close up of a prescription bottle with white tables falling out on top of a group of hundred dollar bills

How celebrity investor Mark Cuban is tackling out-of-control...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that

Market Access

Orphan drugs' financial success raises questions

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.

The UK-US drug pricing deal: A welcome step, but not the fin...

Ozempic tops new Medicare price negotiation list

Looking to history to prepare for America’s uncertain future

How buying Canadian insulin aids Americans without medical c...

How celebrity investor Mark Cuban is tackling out-of-control...

Orphan drugs' financial success raises questions

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

drug prices

Editor's Picks